Astrana Health Statistics
Total Valuation
Astrana Health has a market cap or net worth of $1.65 billion. The enterprise value is $1.75 billion.
| Market Cap | 1.65B |
| Enterprise Value | 1.75B |
Important Dates
The next confirmed earnings date is Thursday, November 6, 2025, after market close.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Astrana Health has 49.93 million shares outstanding. The number of shares has increased by 2.61% in one year.
| Current Share Class | 49.93M |
| Shares Outstanding | 49.93M |
| Shares Change (YoY) | +2.61% |
| Shares Change (QoQ) | +1.27% |
| Owned by Insiders (%) | 12.45% |
| Owned by Institutions (%) | 52.73% |
| Float | 37.56M |
Valuation Ratios
The trailing PE ratio is 63.08 and the forward PE ratio is 18.72. Astrana Health's PEG ratio is 0.63.
| PE Ratio | 63.08 |
| Forward PE | 18.72 |
| PS Ratio | 0.66 |
| Forward PS | 0.42 |
| PB Ratio | 2.12 |
| P/TBV Ratio | 6.78 |
| P/FCF Ratio | 13.59 |
| P/OCF Ratio | 12.62 |
| PEG Ratio | 0.63 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.67, with an EV/FCF ratio of 14.45.
| EV / Earnings | 69.39 |
| EV / Sales | 0.72 |
| EV / EBITDA | 17.67 |
| EV / EBIT | 25.01 |
| EV / FCF | 14.45 |
Financial Position
The company has a current ratio of 1.59, with a Debt / Equity ratio of 0.83.
| Current Ratio | 1.59 |
| Quick Ratio | 1.54 |
| Debt / Equity | 0.83 |
| Debt / EBITDA | 3.98 |
| Debt / FCF | 3.69 |
| Interest Coverage | 2.22 |
Financial Efficiency
Return on equity (ROE) is 5.44% and return on invested capital (ROIC) is 4.52%.
| Return on Equity (ROE) | 5.44% |
| Return on Assets (ROA) | 3.25% |
| Return on Invested Capital (ROIC) | 4.52% |
| Return on Capital Employed (ROCE) | 7.13% |
| Revenue Per Employee | $1.27M |
| Profits Per Employee | $13,294 |
| Employee Count | 1,900 |
| Asset Turnover | 1.80 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Astrana Health has paid $23.70 million in taxes.
| Income Tax | 23.70M |
| Effective Tax Rate | 46.17% |
Stock Price Statistics
The stock price has decreased by -39.50% in the last 52 weeks. The beta is 0.80, so Astrana Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.80 |
| 52-Week Price Change | -39.50% |
| 50-Day Moving Average | 30.39 |
| 200-Day Moving Average | 29.57 |
| Relative Strength Index (RSI) | 58.73 |
| Average Volume (20 Days) | 331,259 |
Short Selling Information
The latest short interest is 1.67 million, so 3.35% of the outstanding shares have been sold short.
| Short Interest | 1.67M |
| Short Previous Month | 1.73M |
| Short % of Shares Out | 3.35% |
| Short % of Float | 4.45% |
| Short Ratio (days to cover) | 5.19 |
Income Statement
In the last 12 months, Astrana Health had revenue of $2.42 billion and earned $25.26 million in profits. Earnings per share was $0.52.
| Revenue | 2.42B |
| Gross Profit | 273.27M |
| Operating Income | 70.07M |
| Pretax Income | 51.35M |
| Net Income | 25.26M |
| EBITDA | 99.21M |
| EBIT | 70.07M |
| Earnings Per Share (EPS) | $0.52 |
Balance Sheet
The company has $342.12 million in cash and $447.59 million in debt, giving a net cash position of -$105.47 million or -$2.11 per share.
| Cash & Cash Equivalents | 342.12M |
| Total Debt | 447.59M |
| Net Cash | -105.47M |
| Net Cash Per Share | -$2.11 |
| Equity (Book Value) | 537.95M |
| Book Value Per Share | 15.58 |
| Working Capital | 269.41M |
Cash Flow
In the last 12 months, operating cash flow was $130.56 million and capital expenditures -$9.32 million, giving a free cash flow of $121.24 million.
| Operating Cash Flow | 130.56M |
| Capital Expenditures | -9.32M |
| Free Cash Flow | 121.24M |
| FCF Per Share | $2.43 |
Margins
Gross margin is 11.30%, with operating and profit margins of 2.90% and 1.04%.
| Gross Margin | 11.30% |
| Operating Margin | 2.90% |
| Pretax Margin | 2.12% |
| Profit Margin | 1.04% |
| EBITDA Margin | 4.10% |
| EBIT Margin | 2.90% |
| FCF Margin | 5.01% |
Dividends & Yields
Astrana Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.61% |
| Shareholder Yield | -2.61% |
| Earnings Yield | 1.53% |
| FCF Yield | 7.36% |
Analyst Forecast
The average price target for Astrana Health is $47.40, which is 43.68% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $47.40 |
| Price Target Difference | 43.68% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 20.41% |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Astrana Health has an Altman Z-Score of 3.64 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.64 |
| Piotroski F-Score | 6 |